The effects of dihydroergotamine in patients with head injury and raised intracranial pressure

Intensive Care Medicine
P O Grände

Abstract

In the first study 6 patients with raised intracranial pressure due to brain oedema following head injury were given dihydroergotamine because of low perfusion pressure. The intracranial pressure fell simultaneously with the increase in arterial pressure. The intracranial pressure fell from 24 +/- 2 mmHg by a maximum of 12 +/- 1 mmHg after a single intravenous injection of 0.25 mg of dihydroergotamine and remained at a low level for 35-70 min before stabilizing at a new level 5 +/- 1 mmHg below the baseline. The initial rapid and marked decrease in intracranial pressure may be the result of a reduced intracranial blood volume, due predominantly to constriction of the more voluminous venous capacitance vessels (by analogy with the corresponding vascular effect of dihydroergotamine on skeletal muscle and skin.) In the second study, experiments using sympathectomized cat skeletal muscle, showed that dihydroergotamine also reduced the hydrostatic capillary pressure, inducing absorption of fluid from the interstitial tissue to blood. It is suggested that a similar transcapillary absorption effect in the damaged brain may be an explanation for the observation that the intracranial pressure stabilized at a level below the initial one ...Continue Reading

References

May 1, 1979·The Annals of Thoracic Surgery·L NuñezP Celemin
Mar 1, 1987·Acta Physiologica Scandinavica·S MellanderR Myrhage
Jan 1, 1987·Stroke; a Journal of Cerebral Circulation·A R AndersenN A Lassen
Jun 1, 1974·Acta Physiologica Scandinavica·P O GrändeS Mellander
Sep 1, 1984·Neurosurgery·J H Piatt, S J Schiff
Mar 1, 1984·Journal of Neurosurgery·D J BoariniH C Coester

❮ Previous
Next ❯

Citations

May 1, 1992·Acta Anaesthesiologica Scandinavica·W SchalénC H Nordström
Oct 1, 1995·Acta Anaesthesiologica Scandinavica·F NilssonC H Nordström
Oct 1, 1995·Acta Anaesthesiologica Scandinavica·B AsgeirssonH Sjöholm
May 1, 1996·Acta Anaesthesiologica Scandinavica·F NilssonC H Nordström
Jan 9, 1998·Acta Anaesthesiologica Scandinavica·F NilssonC H Nordström
Oct 3, 2008·Neurosurgical Focus·Timothy Y TranJohn W German
Jan 1, 1990·Intensive Care Medicine·L Beretta
Nov 17, 2009·Brain Injury : [BI]·Catherine Aaro JonssonIngrid Emanuelson
Jun 22, 2002·The Cochrane Database of Systematic Reviews·F LombardiA Liberati
Jul 5, 2017·Frontiers in Neurology·Carl-Henrik NordströmMagnus Olivecrona

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.